Kingsmen Resources Ltd
XTSX:KNG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kingsmen Resources Ltd
XTSX:KNG
|
CA |
|
TransUnion
NYSE:TRU
|
US |
|
C
|
China Sanjiang Fine Chemicals Co Ltd
HKEX:2198
|
CN |
|
B
|
Beijing YanDong MicroElectronic Co Ltd
SSE:688172
|
CN |
|
PhosAgro PAO
LSE:PHOR
|
RU |
|
C
|
China Medical System Holdings Ltd
HKEX:867
|
CN |
|
E
|
Eli Lilly and Co
BMV:LLY
|
US |
|
Masimo Corp
NASDAQ:MASI
|
US |
|
Align Technology Inc
NASDAQ:ALGN
|
US |
|
Secom Co Ltd
TSE:9735
|
JP |
|
Kiplin Metals Inc
F:17G1
|
CA |
|
L
|
LAI YIH Footware Co Ltd
TWSE:6890
|
KY |
|
Far Eastern New Century Corp
TWSE:1402
|
TW |
|
BIOLASE Inc
OTC:BIOLQ
|
US |
|
Eastparc Hotel Tbk PT
IDX:EAST
|
ID |
Balance Sheet
Balance Sheet Decomposition
Kingsmen Resources Ltd
Kingsmen Resources Ltd
Balance Sheet
Kingsmen Resources Ltd
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
3
|
2
|
1
|
3
|
1
|
0
|
0
|
1
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Cash Equivalents |
0
|
0
|
3
|
2
|
1
|
3
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
3
|
2
|
1
|
3
|
2
|
1
|
0
|
1
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| PP&E Net |
0
|
1
|
2
|
3
|
1
|
3
|
5
|
4
|
4
|
4
|
4
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
2
|
3
|
1
|
3
|
5
|
4
|
4
|
4
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
1
+232%
|
5
+378%
|
5
+11%
|
2
-61%
|
6
+161%
|
7
+21%
|
5
-30%
|
4
-10%
|
5
+19%
|
6
+11%
|
3
-46%
|
3
0%
|
1
-74%
|
1
-27%
|
0
-33%
|
0
-35%
|
1
+133%
|
1
+24%
|
1
+13%
|
1
+11%
|
1
+3%
|
1
+35%
|
2
+41%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
0
+133%
|
0
-57%
|
0
-17%
|
0
+140%
|
0
+100%
|
0
N/A
|
0
-58%
|
0
+50%
|
0
+20%
|
0
+28%
|
0
-91%
|
0
-25%
|
0
+40%
|
0
-9%
|
0
-54%
|
0
+149%
|
0
-60%
|
0
+56%
|
0
-45%
|
0
+552%
|
0
+26%
|
0
+27%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
0
|
1
|
6
|
8
|
8
|
12
|
13
|
13
|
14
|
15
|
17
|
17
|
17
|
18
|
18
|
18
|
18
|
18
|
19
|
19
|
19
|
19
|
2
|
3
|
|
| Retained Earnings |
0
|
0
|
1
|
3
|
7
|
8
|
8
|
11
|
12
|
12
|
13
|
16
|
16
|
19
|
19
|
19
|
19
|
20
|
20
|
20
|
18
|
18
|
0
|
1
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
0
|
|
| Total Equity |
0
N/A
|
1
+213%
|
5
+393%
|
5
+13%
|
2
-61%
|
6
+161%
|
7
+19%
|
5
-32%
|
4
-8%
|
5
+18%
|
5
+11%
|
3
-48%
|
3
+7%
|
1
-74%
|
1
-28%
|
0
-34%
|
0
-34%
|
1
+132%
|
1
+27%
|
1
+12%
|
1
+12%
|
1
-1%
|
1
+35%
|
2
+41%
|
|
| Total Liabilities & Equity |
0
N/A
|
1
+232%
|
5
+378%
|
5
+11%
|
2
-61%
|
6
+161%
|
7
+21%
|
5
-30%
|
4
-10%
|
5
+19%
|
6
+11%
|
3
-46%
|
3
0%
|
1
-74%
|
1
-27%
|
0
-33%
|
0
-35%
|
1
+133%
|
1
+24%
|
1
+13%
|
1
+11%
|
1
+3%
|
1
+35%
|
2
+41%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
0
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
4
|
5
|
6
|
6
|
8
|
9
|
9
|
9
|
9
|
17
|
25
|
12
|
14
|
14
|
19
|
23
|
|